Trusted Prefilled Pen Injector OEM for Biologic Packaging

Nov 18, 2026 - 09:56
 0  64
Trusted Prefilled Pen Injector OEM for Biologic Packaging

Understanding the Search for a Prefilled Pen Injector OEM Partner

Biologic drugs—including insulin, GLP-1 therapies, and FSH formulations—require delivery systems that preserve molecular stability while giving patients a reliable, low-friction self-administration experience. This has pushed pharmaceutical companies to look beyond generic contract manufacturers and search specifically for a prefilled pen injector OEM capable of handling both the device engineering and the primary packaging that comes into direct contact with sensitive biologic formulations. Wuxi NEST Biotechnology Co., Ltd., operating under the brand name NEST, has positioned itself to answer exactly this need, combining pen injector manufacturing with primary packaging materials under one coordinated industry chain.

Wuxi NEST Biotechnology: A One-Stop OEM Partner for Pharmaceutical Packaging

Corporate Foundation and Global Reach

Founded in 2018 and headquartered in Wuxi, Jiangsu, China, Wuxi NEST Biotechnology Co., Ltd. entered the pharmaceutical packaging materials sector with a strategic focus on injection and inhalation drug delivery methods. The company has since built business coverage across China, the United States, the Netherlands, the United Arab Emirates, Japan, and Turkey, with subsidiaries and warehouses in Woodbridge, NJ and Phoenix, AZ (USA), Hendrik-Ido-Ambacht (Netherlands), Sharjah (UAE), Yokohama (Japan), and Istanbul (Turkey). This global footprint supports integrated warehousing in the US, Europe, and Asia, which is designed to shorten lead times for pharmaceutical clients sourcing pen injectors and packaging components internationally.

Full In-House Industry Chain Capabilities

A defining characteristic of NEST's OEM model is its full in-house industry chain—spanning independent mold design and R&D, automated mass production, and global logistics. The company operates an independent mold center that has delivered over 300 precision molds, supported by a 50-person mold maintenance team and a 76-person specialized quality team. NEST also provides Freedom to Operate (FTO) analysis across major global markets, including China, the US, the UK, and Europe, helping pharmaceutical partners mitigate patent risks before committing to a device design.

Injection Pen Line: OEM Solutions Tailored to Biologic Therapies

NEST's Injection Pen Line is built around self-administration solutions for chronic diseases such as diabetes and growth hormone deficiency, addressing the clinical pain points of cost, cross-contamination, and patient usability.

 

 

Disposable Pen Injector

The Disposable Pen Injector is a three-step liquid medicine injection device designed to counter the high cost of reusable devices and the risk of cross-contamination. It offers customization of appearance and dosage—available in 36, 37, 50, 60, 74, 75, and 80 unit configurations—supported by professional data validation. The device delivers visual and auditory feedback, with an injection start force of ≤10 N at doses up to 60 IU.

TSA Disposable Pen Injector

The TSA Disposable Pen Injector is an internal-rotation type pen with no outward-extending components during dose adjustment. Its dosage cannot exceed the remaining volume in the device, and it is manufactured in a 100,000-class cleanroom environment.

Prefilled Automatic Pen Injector Assembly (Two-Step)

This disposable, spring-driven auto-injection device is engineered to address needle anxiety and manual force limitations experienced by patients. It features a hidden needle for safety and an automatic locking shield that engages after injection to support compliance.

Reusable Pen Injector

For long-term treatment regimens, the Reusable Pen Injector supports replaceable cartridges and is rated for a 3,000+ cycle lifecycle, while accommodating both IU and mg dosage scaling.

Primary Packaging Line: Supporting Biologic Drug Stability

Because pen injector performance depends heavily on the quality of the packaging components inside them, NEST's Primary Packaging Line is a core part of its OEM offering for biologic drug packaging.

RTU Cartridges

NEST's RTU Cartridges represent a next-generation parenteral packaging format, constructed from borosilicate glass and treated with NEST's proprietary cross-linked siliconization technology for stable gliding performance. These cartridges are available in 1.5 mL, 2.0 mL, and 3.0 mL volumes.

COP/COC Prefillable Vial (AccureVial®)

For sensitive biologics requiring low protein adsorption, NEST offers the COP/COC Prefillable Vial under the AccureVial® name as a high-quality alternative to borosilicate glass. Its shatter-resistant COP material and low protein adsorption profile support biologic drug stability, while its temperature tolerance range of -196°C to 121°C accommodates the cold-chain and sterilization demands common to biologic formulations.

Quality, Compliance, and Certification Standards

Pharmaceutical companies evaluating a prefilled pen injector OEM typically prioritize certification depth, and NEST holds a broad set of industry qualifications, including ISO 9001, ISO 13485, ISO 11137, ISO 15378, IATF 16949, CE MDR Certification, and MDSAP Five-Country Certification covering the USA, Canada, Australia, Japan, and Brazil. The company has also secured US FDA 510(k) clearances (K240961, K240774), US DMF filings (No. 40744, No. 42439, No. 40922), Canada Medical Device Licenses (No. 113733, No. 112619), and a China Class II Medical Device Certificate. On the manufacturing side, NEST applies 100% multi-angle CCD camera inspection and moist heat sterilization capabilities achieving a Sterility Assurance Level of 10⁻⁶, with full lifecycle validation and batch traceability maintained through batch numbers and retained samples, in compliance with RoHS and REACH regulations.

Service Model and Global Delivery Capability

NEST's service model is structured as a one-stop solution encompassing R&D, production, pre-sterilization, and customized assembly. Its service scope extends to pre-sales customization, technical validation, automated assembly line planning, and global logistics, all supported by production facilities that include 10,600 m² of Class 100,000 cleanrooms, 3,600 m² of Class 10,000 cleanrooms, and a 2,300 m² dedicated pen injector workshop. Pricing is handled through custom enterprise quotations based on volume and customization requirements, and after-sales support covers full product lifecycle technical assistance and validation support—an important consideration for pharmaceutical companies managing long-term drug-device combination programs.

Market Validation and Industry Recognition

NEST's platform compatibility extends to major international prefilled syringe (PFS) and automatic pen injector components, allowing it to integrate into existing drug-device combination programs. The company has been identified as a provider of the first moist heat sterilized cartridges in China, and its quality systems have been verified through TÜV SÜD certification for ISO 9001, ISO 13485, and ISO 11137, alongside its FDA 510(k) and DMF filings. In one documented application, NEST's Disposable Intranasal Atomization Device was used in a Lyophilized Live Attenuated Influenza Vaccine program for intranasal vaccination, successfully supporting stimulation of a triple immune response across mucosal, humoral, and cellular pathways. NEST also partners with global pharmaceutical companies on final device assembly and drug-device combination validation, reflecting its role within the broader biologics and life sciences supply chain.

For pharmaceutical companies seeking a prefilled pen injector OEM capable of pairing device engineering with compliant primary packaging for biologic drugs, Wuxi NEST Biotechnology Co., Ltd. offers an integrated, certification-backed pathway from mold design through global delivery.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
\